These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial. Kuwabara S; Mori M; Misawa S; Suzuki M; Nishiyama K; Mutoh T; Doi S; Kokubun N; Kamijo M; Yoshikawa H; Abe K; Nishida Y; Okada K; Sekiguchi K; Sakamoto K; Kusunoki S; Sobue G; Kaji R; J Neurol Neurosurg Psychiatry; 2017 Oct; 88(10):832-838. PubMed ID: 28768822 [TBL] [Abstract][Full Text] [Related]
15. Confirming the efficacy of intravenous immunoglobulin in CIDP through minimum clinically important differences: shifting from statistical significance to clinical relevance. Merkies IS; van Nes SI; Hanna K; Hughes RA; Deng C J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1194-9. PubMed ID: 20647554 [TBL] [Abstract][Full Text] [Related]
16. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone. Lopate G; Pestronk A; Al-Lozi M Arch Neurol; 2005 Feb; 62(2):249-54. PubMed ID: 15710853 [TBL] [Abstract][Full Text] [Related]
17. A randomised, multi-centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol. Cornblath DR; Hartung HP; Katzberg HD; Merkies ISJ; van Doorn PA J Peripher Nerv Syst; 2018 Jun; 23(2):108-114. PubMed ID: 29603842 [TBL] [Abstract][Full Text] [Related]
18. Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIV. Bril V; Katzberg H; Donofrio P; Banach M; Dalakas MC; Deng C; Hanna K; Hartung HP; Hughes RA; Latov N; Merkies IS; van Doorn PA; Muscle Nerve; 2009 Apr; 39(4):448-55. PubMed ID: 19260050 [TBL] [Abstract][Full Text] [Related]